Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in
Pharmaceutical Technology
JUNE 23, 2025
Can pharma tariffs “Make America Manufacture Again”? Alvotech has moved one step closer to entering the Eylea (aflibercept 2 mg) biosimilar market, after a European Medicines Agency (EMA) panel recommended approval of its copycat biologic. CucuMberStudio via Shutterstock.
Let's personalize your content